No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
TD Cowen Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating
Cantor Fitzgerald Reiterates Overweight on Agios Pharmaceuticalsto Overweight
The European Commission Has Adopted A Positive Decision For The Designation Of Agios Pharmaceuticals' Mitapivat As An Orphan Medicinal Product For Sickle Cell Disease
European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios' Mitapivat in Sickle Cell Disease
Tesla, Micron, Broadcom, MARA Holdings And Other Big Stocks Moving Higher On Monday
Here's Why Agios Stock Plummeted More Than 20% on Monday